首页> 外文期刊>Molecular & cellular proteomics: MCP >Proteomic Analysis of Urothelium of Rats with Detrusor Overactivity Induced by Bladder Outlet Obstruction
【24h】

Proteomic Analysis of Urothelium of Rats with Detrusor Overactivity Induced by Bladder Outlet Obstruction

机译:膀胱出口梗阻诱导尿液过度抗性大鼠尿路鞘核蛋白质组学分析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Overactive bladder (OAB) syndrome is a condition that has four symptoms: urgency, urinary frequency, nocturia, and urge incontinence and negatively affects a patient's life. Recently, it is considered that the urinary bladder urothelium is closely linked to pathogenesis of OAB. However, the mechanisms of pathogenesis of OAB at the molecular level remain poorly understood, mainly because of lack of modern molecular analysis. The goal of this study is to identify a potential target protein that could act as a predictive factor for effective diagnosis and aid in the development of therapeutic strategies for the treatment of OAB syndrome. We produced OAB in a rat model and performed the first proteomic analysis on the mucosal layer (urothelium) of the bladders of sham control and OAB rats. The resulting data revealed the differential expression of 355 proteins in the bladder urothelium of OAB rats compared with sham subjects. Signaling pathway analysis revealed that the differentially expressed proteins were mainly involved in the inflammatory response and apoptosis. Our findings suggest a new target for accurate diagnosis of OAB that can provide essential information for the development of drug treatment strategies as well as establish criteria for screening patients in the clinical environment.
机译:过度活性膀胱(OAB)综合征是具有四种症状的病症:紧急性,尿频,夜尿和急迫失禁,对患者的生命产生负面影响。最近,认为尿膀胱尿路鞘细胞与OAB的发病机制密切相关。然而,在分子水平下,OAb的发病机制仍然明显,主要是因为缺乏现代分子分析。本研究的目的是鉴定潜在的靶蛋白,其可以作为有效诊断和援助在制定治疗OAB综合征的治疗策略方面的预测因素。我们在大鼠模型中产生OAB,并对假手术和OAb大鼠的粘膜层(尿路鞘)进行第一蛋白质组学分析。得到的数据显示,与假对象相比,将355蛋白355蛋白的差异表达。信号传导途径分析显示,差异表达的蛋白质主要涉及炎症反应和凋亡。我们的研究结果表明,准确诊断OAB的新目标,可以为制定药物治疗策略的发展,以及建立临床环境中筛查患者的标准。

著录项

  • 来源
  • 作者单位

    KBSI Div Bioconvergence Anal Drug &

    Dis Target Team Cheongju 28119 South Korea;

    Chungnam Natl Univ Sch Med Dept Urol Daejeon 35015 South Korea;

    KBSI Div Bioconvergence Anal Drug &

    Dis Target Team Cheongju 28119 South Korea;

    KBSI Div Bioconvergence Anal Drug &

    Dis Target Team Cheongju 28119 South Korea;

    KBSI Div Bioconvergence Anal Drug &

    Dis Target Team Cheongju 28119 South Korea;

    KBSI Div Bioconvergence Anal Drug &

    Dis Target Team Cheongju 28119 South Korea;

    KBSI Div Bioconvergence Anal Drug &

    Dis Target Team Cheongju 28119 South Korea;

    KBSI Div Bioconvergence Anal Drug &

    Dis Target Team Cheongju 28119 South Korea;

    KBSI Div Bioconvergence Anal Drug &

    Dis Target Team Cheongju 28119 South Korea;

    Chungnam Natl Univ Res Ctr Endocrine &

    Metab Dis Sch Med Daejeon 35015 South Korea;

    Chungnam Natl Univ Res Ctr Endocrine &

    Metab Dis Sch Med Daejeon 35015 South Korea;

    Chungnam Natl Univ Sch Med Dept Urol Daejeon 35015 South Korea;

    Chungnam Natl Univ Sch Med Dept Urol Daejeon 35015 South Korea;

    KBSI Div Bioconvergence Anal Drug &

    Dis Target Team Cheongju 28119 South Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号